JPMorgan Chase & Co. Increases Stock Position in Sapiens International Co. (NASDAQ:SPNS)

JPMorgan Chase & Co. raised its position in Sapiens International Co. (NASDAQ:SPNS) by 22.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 177,878 shares of the technology company’s stock after acquiring an additional 32,780 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.32% of Sapiens International worth $6,630,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. National Bank of Canada FI purchased a new position in Sapiens International during the 3rd quarter valued at about $26,000. Financial Management Professionals Inc. grew its position in shares of Sapiens International by 57.9% in the 3rd quarter. Financial Management Professionals Inc. now owns 1,945 shares of the technology company’s stock worth $72,000 after buying an additional 713 shares during the last quarter. MQS Management LLC purchased a new position in shares of Sapiens International during the third quarter valued at approximately $230,000. HighTower Advisors LLC bought a new position in shares of Sapiens International during the third quarter valued at approximately $231,000. Finally, Vanguard Personalized Indexing Management LLC purchased a new stake in Sapiens International in the second quarter worth $232,000. 30.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SPNS has been the topic of a number of research analyst reports. Barclays reduced their price objective on shares of Sapiens International from $38.00 to $30.00 and set an “underweight” rating on the stock in a research report on Tuesday, November 12th. StockNews.com cut shares of Sapiens International from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 19th. William Blair restated a “market perform” rating on shares of Sapiens International in a report on Friday, December 6th. Finally, Needham & Company LLC reduced their target price on Sapiens International from $44.00 to $35.00 and set a “buy” rating on the stock in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $36.00.

Sapiens International Stock Up 1.6 %

NASDAQ:SPNS opened at $25.90 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.18 and a quick ratio of 2.18. The firm’s 50-day moving average price is $27.86 and its 200-day moving average price is $33.48. The company has a market capitalization of $1.45 billion, a PE ratio of 20.39 and a beta of 1.15. Sapiens International Co. has a 1-year low of $25.01 and a 1-year high of $41.22.

Sapiens International (NASDAQ:SPNS) last announced its quarterly earnings data on Monday, November 11th. The technology company reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). Sapiens International had a return on equity of 17.61% and a net margin of 13.23%. The business had revenue of $137.00 million during the quarter, compared to analysts’ expectations of $140.10 million. During the same quarter last year, the company posted $0.32 EPS. Sapiens International’s revenue for the quarter was up 4.8% compared to the same quarter last year. On average, equities analysts predict that Sapiens International Co. will post 1.42 EPS for the current fiscal year.

Sapiens International Company Profile

Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.